SIGMA-ALDRICH search Sigma-Aldrich CD3D products
includes other brands or spellings
|
| ih | | Sigma anti-CD3 antibody was used in immunohistochemistry to study S100A8 and S100A9 expression in human arterial wall. |
SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology CD3D products
includes other brands or spellings
|
| ip, wb | | Santa Cruz Biotechnology anti-CD3 antibody (OKT3) was used in human Jurkat cells and in immunoprecipitation, western blot to study the association of RanBPM with the plasma membrane and the interaction with the integrin LFA-1. |
R & D SYSTEMS search R & D Systems CD3D products
includes other brands or spellings
|
| ih | | R&D Systems mouse anti-human CD3 antibody was used in immunohistochemistry to study the expression, localization, and functional activity of TL1A in inflammatory bowel disease. |
BD BIOSCIENCES search BD Biosciences CD3D products
includes other brands or spellings
|
| block | | BD Biosciences plate bound anti-CD3 antibody was used in activating expriments to study the role of Rip2 in Bcl10 signaling and T-cell receptor-mediated NF- B activation. |
| block | | BD PharMingen anti-CD3 antibody (clone 145-2C11) antibody was used in blocking or activating expriments to study the effect of ectopic B-Raf expression in T Cells. |
| flow, ih | | PharMingen mouse anti-human CD3-APC antibody (IgG1, clone UCHT1) was used in flow cytometry and immunohistochemistry to study the CCR10 expression in circulating and mucosal epithelial tissue IgA Ab-secreting cells. |
| flow, wb | | BD FITC-labeled anti-CD3 (Leu-4) antibody was used in flow cytometry to study the lck degradation and refractory state in CD8+ cytotoxic T lymphocytes. |
| flow | | BD Biosciences anti-CD3–biotin antibody was used in flow cytometry to study the function of protein phosphatase subunit G5PR in B cell receptor–induced apoptosis. |
| flow | | BD Pharmingen FITC-conjugated monoclonal anti-CD3 antibody was used in flow cytometry to study the interaction of human lymphocytes with CD47 through a novel member of the signal regulatory protein (SIRP) family. |
| flow | | BD Biosciences CD3 specific antibody (clone UCHT1) was used in flow cytometry to study the resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model. |
| flow | | BD PharMingen monoclonal FITC-conjugated mouse anti-human CD3 was used in flow cytometry to study the immunologic characterization of a novel cDNA coding for progesterone-induced blocking factor through its effect on cytokine expression. |
| ic | | Becton Dickinson monoclonal antibody against CD3 was used in immunocytochemistry to demonstrate the role of indoleamine 2, 3-dioxygenase in NK cells. |
INVITROGEN search Invitrogen CD3D products
includes other brands or spellings
|
| ip | | Dynal ASA mouse monoclonal antibody specific for CD3 was used in immunoprecipitation to demonstrate the role of indoleamine 2, 3-dioxygenase in NK cells. |
ATCC search ATCC CD3D products
includes other brands or spellings
|
| block, flow | | American Type Culture Collection CD3 antibody (clone CRL 8001) was used in flow cytometry and activating experiments to study the regulation of LFA-1 activation. |
BECKMAN COULTER search Beckman Coulter CD3D products
includes other brands or spellings
|
| flow | | Dako monoclonal murine antibodies against CD3 conjugated to fluorescein isothiocyanate and phosphatidylethanolamine were used in flow cytometry to characterize Lyp in the Bcr-Abl signal transduction pathway. |
| flow | | Immunotech FITC-anti-CD3 antibody was used in flow cytometry to analyze surface molecules in high density, CD27-depleted tonsil B lymphocytes from human tonsil tissue of 3- to 15-year-old donors. |
| flow | | Beckman Coulter FITC-conjugated anti-CD3 antibody was used in flow cytometry to study phospholipases A2 in human neutrophils. |
| ic, ih, wb | | Dako monoclonal anti-CD3 antibody was used in western blot, immunohistochemistry and immunocytochemistry to study the interaction between the spermatogenic zip protein Spz1 and protein phosphatase-1 (PP1) regulatory protein in mouse testis. |
| ic, ih | | Dako Corporation anti-CD3 antibody was used in immunohistochemistry and immunocytochemistry to study the increased expression of transforming growth factor-ß1 as a stabilizing factor in human atherosclerotic plaques. |
| ih | | DAKO rabbit anti-human CD3 antibody was used inimmunohistochemistry to study Kv1.3 expression on inflammatory infiltrates in multiple sclerosis brain. |
| ih | | Dako CD3 antibody was used in immunohistochemistry to study the biological function of D816V mutation in patients with mastocytosis. |
| ih | | DakoCytomation antibody against CD3 was used in immunohistochemistry to study the a number of roles for fractalkine in the endometrium, in the secretory phase, in early pregnancy, and when influenced by progestin-only contraceptives. |
| ih | | Dakocytomation mouse monoclonal human T lymphocyte antigen CD3 antibody (clone T3-4B5) was used in immunohistochemistry to study its localization in Monckeberg's sclerosis and atherosclerosis. |
| ih | | Dako Cytomation polyclonal CD3 antibody was used in immunohistochemistry to study OCT-1, OCT-2, and BOB-1/OCA-B expression in normal lymphoid tissue and in T-cell neoplasms. |
| ih | | Dako CD3 antibody was used in immunohistochemistry to study SFTPC gene mutation in an interstitial lung disease patient. |
BIOCARTA
|
| ih | | BioCarta monoclonal CD3 antibody was used in immunohistochemistry to study OCT-1, OCT-2, and BOB-1/OCA-B expression in normal lymphoid tissue and in T-cell neoplasms. |
NOVOCASTRA
|
| ic | | NovoCastra CD3 antibody was used in immunocytochemistry to study the cloning and characterization of a cancer-associated cell membrane glycoprotein, dysadherin. |
| ih | | NovoCastra monoclonal anti-CD3 antibody was used in immunohistochemistry to study Kv1.3 expression on inflammatory infiltrates in multiple sclerosis brain. |
STEMCELL TECHNOLOGIES
|
| flow | | StemCell Technologies CD3 antibody was used in flow cytometry to study the survival effect of tumour necrosis factor-alpha in human neutrophils. |
| flow | | StemCell Technologies RosetteSep Monocyte Enrichment Cocktail CD3 antibody was used to study adrenomedullin expression in blood monocytes associated with acute kawasaki disease. |
Articles Reviewed |
| 1. Norbert Degousee et al. Groups IV, V, and X phospholipases A2s in human neutrophils: role in eicosanoid production and gram-negative bacterial phospholipid hydrolysis. 2002 |
| 2. Yoshinori Ino et al. Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis. 2002 |
| 3. Marco Herling et al. TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin. 2003 |
| 4. Teresa Marafioti et al. Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms. 2003 |
| 5. Eric J Kunkel et al. CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells. 2003 |
| 6. Wenwen Chien et al. Characterization of a myeloid tyrosine phosphatase, Lyp, and its role in the Bcr-Abl signal transduction pathway. 2003 |
| 7. Tara J Dillon et al. Ectopic B-Raf expression enhances extracellular signal-regulated kinase (ERK) signaling in T cells and prevents antigen-presenting cell-induced anergy. 2003 |
| 8. Giorgos Bamias et al. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. 2003 |
| 9. Patricia K A Mongini et al. Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis. 2003 |
| 10. Louise S Villadsen et al. Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model. 2003 |
| 11. Beata Polgar et al. Molecular cloning and immunologic characterization of a novel cDNA coding for progesterone-induced blocking factor. 2003 |
| 12. Astrid A Ruefli-Brasse et al. Rip2 participates in Bcl10 signaling and T-cell receptor-mediated NF-kappaB activation. 2004 |
| 13. Simona Denti et al. RanBPM is a phosphoprotein that associates with the plasma membrane and interacts with the integrin LFA-1. 2004 |
| 14. S Kai et al. Indoleamine 2,3-dioxygenase is necessary for cytolytic activity of natural killer cells. 2004 |
| 15. S R Walmsley et al. Characterization of the survival effect of tumour necrosis factor-alpha in human neutrophils. 2004 |
| 16. Michael Schoppet et al. Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Mönckeberg's sclerosis and atherosclerosis. 2004 |
| 17. F Brasch et al. Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene. 2004 |
| 18. Gary Brooke et al. Human lymphocytes interact directly with CD47 through a novel member of the signal regulatory protein (SIRP) family. 2004 |
| 19. Francesco Cipollone et al. Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 2004 |
| 20. Marcia L Taylor et al. Demonstration that mast cells, T cells, and B cells bearing the activating kit mutation D816V occur in clusters within the marrow of patients with mastocytosis. 2004 |
| 21. Ichiro Nomura et al. Adrenomedullin is highly expressed in blood monocytes associated with acute Kawasaki disease: a microarray gene expression study. 2005 |
| 22. Natalie J Hannan et al. Coexpression of fractalkine and its receptor in normal human endometrium and in endometrium from users of progestin-only contraception supports a role for fractalkine in leukocyte recruitment and endometrial remodeling. 2004 |
| 23. Michael Uhlin et al. Regulation of lck degradation and refractory state in CD8+ cytotoxic T lymphocytes. 2005 |
| 24. Horea Rus et al. The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain. 2005 |
| 25. Yan Xing et al. Protein phosphatase subunit G5PR is needed for inhibition of B cell receptor-induced apoptosis. 2005 |
| 26. Michelle M McCormick et al. S100A8 and S100A9 in human arterial wall. Implications for atherogenesis. 2005 |
| 27. Susanna C Fagerholm et al. Specific integrin alpha and beta chain phosphorylations regulate LFA-1 activation through affinity-dependent and -independent mechanisms. 2005 |